rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

BGM Group Ltd. - Class A

BGM · Nasdaq

Health CareBiotechnologyNot moving yet

BGM stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 13.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
11 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders11+0 on the quarter
New · exited3 · 3
Reported value$119K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202698,472$36K+51,511+109.7%
XTX Topco Ltdadded · filed 14 Aug 202663,089$23K+51,652+451.6%
UBS Group AGadded · filed 13 Aug 202657,646$21K+55,694+2853.2%
JANE STREET GROUP, LLCnew · filed 14 Aug 202657,227$21K+57,227
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 202632,067$12K+16,330+103.8%
Ground Swell Capital, LLCnew · filed 5 Aug 202611,101$4,081+11,101
JPMORGAN CHASE & COnew · filed 12 Aug 20261,815$681+1,815
ROYAL BANK OF CANADAreduced · filed 14 Aug 20261,499$1,000-507−25.3%
MORGAN STANLEYunchanged · filed 13 Aug 2026200$7400.0%
SBI Securities Co., Ltd.added · filed 23 Jul 20269$3+6+200.0%
30 Jun 2024 – 30 Jun 2026
2711Jun 24Dec 24Jun 25Dec 25Jun 26

News

No headline names it lately.

Everyone who traded it

Nobody on record has traded it.

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 30 Sep 202516.6%
Operating profit marginFY 2025 · to 30 Sep 2025-33.2%
Free cash flow marginFY 2025 · to 30 Sep 2025-10.4%
Return on capital employedFY 2025 · to 30 Sep 2025-3.2%
Research spendFY 2025 · to 30 Sep 20251.8%
Revenue growthFY 2025 · to 30 Sep 202551.1%
Share count trendFY 2024 · to 30 Sep 2024-79.8%
Cash and equivalentsFY 2025 · to 30 Sep 2025$9.8M
Free cash flowFY 2025 · to 30 Sep 2025−$3.9M

Analyst forecasts

No analyst forecasts yet.